Skip to Content

Fluidigm to Present at the 25th Annual Piper Jaffray Healthcare Conference

Nov 27, 2013

Piper Jaffray Healthcare Conference 2013

SOUTH SAN FRANCISCO, Calif. – Nov. 27, 2013 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Financial Officer Vikram Jog and  Vice President of Corporate Development Un Kwon-Casado will present at the 25th Annual Piper Jaffray Healthcare Conference in New York City, on Wednesday, December 4, 2013, at 2:00 p.m. (EST).

Audio of Fluidigm's presentation will be webcast at:
http://www.media-server.com/m/p/rne3fufq.

The webcast will be archived for 90 days following the live presentation.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including 18 different commercial IFCs for nucleic acid analysis, and three families of assay chemistries. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm products are provided: For Research Use Only. Not for use in diagnostic procedures.

For more information, please visit www.fluidigm.com.

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

Contact
Michaeline Bunting
Senior Director, Marketing
Fluidigm Corporation
650 737 4190
michaeline.bunting@fluidigm.com